The total return over the past 12 months is -18.69% vs. +16.94% for the S&P 500. So far it's up +9.42% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (18.69%) | +1.99% | N/A | N/A | N/A | N/A |
| Total Return CAGR | (18.69%) | +1.99% | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MiNK Therapeutics, Inc. (INKT)
| Year | Start price | End price | INKT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.15 | $12.20 | +9.42% | +14.51% | (5.09%) |
| 2025 | $6.97 | $11.15 | +59.97% | +17.72% | +42.25% |
| 2024 | $10.70 | $6.97 | (34.86%) | +24.89% | (59.75%) |
| 2023 | $26.10 | $10.70 | (59.00%) | +26.19% | (85.19%) |
| 2022 | $44.60 | $26.10 | (41.48%) | (18.17%) | (23.31%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
